EUGENIE S KLEINERMAN to Cells, Cultured
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Cells, Cultured.
Connection Strength
0.252
-
VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature. Angiogenesis. 2008; 11(3):257-67.
Score: 0.042
-
Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo. Clin Cancer Res. 2002 Nov; 8(11):3622-7.
Score: 0.029
-
ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity. Cancer Immunol Immunother. 1999 Sep; 48(6):312-20.
Score: 0.023
-
Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. J Pharmacol Exp Ther. 1994 Feb; 268(2):1032-9.
Score: 0.016
-
Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression. Cancer Immunol Immunother. 1993 Nov; 37(6):408-11.
Score: 0.016
-
Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro. Cancer Commun. 1991; 3(10-11):313-21.
Score: 0.013
-
Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication. J Immunol. 1990 Mar 01; 144(5):1942-53.
Score: 0.012
-
Differential release of TNF-alpha, IL 1, and PGE2 by human blood monocytes subsequent to interaction with different bacterial derived agents. Lymphokine Res. 1990; 9(4):449-63.
Score: 0.012
-
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol Ther. 2009 Oct; 17(10):1779-87.
Score: 0.011
-
Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res. 1988 May 01; 48(9):2604-9.
Score: 0.011
-
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome. J Clin Oncol. 1985 Jul; 3(7):1005-12.
Score: 0.009
-
Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst. Cancer Res. 1985 May; 45(5):2058-64.
Score: 0.009
-
Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines. J Leukoc Biol. 1985 Apr; 37(4):461-72.
Score: 0.009
-
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line. Cancer Res. 1984 Oct; 44(10):4470-5.
Score: 0.008
-
Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J Clin Oncol. 1984 Aug; 2(8):937-43.
Score: 0.008
-
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide. Cancer Res. 1983 May; 43(5):2010-4.
Score: 0.008
-
In vitro cellular regulation of monocyte function: evidence for a radiosensitive suppressor. J Reticuloendothel Soc. 1981 Nov; 30(5):373-80.
Score: 0.007
-
Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II). Cancer Res. 1980 Sep; 40(9):3099-102.
Score: 0.006
-
Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. Cancer Res. 1985 Dec; 45(12 Pt 1):6188-93.
Score: 0.002
-
Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro. Am J Pathol. 1983 Jul; 112(1):101-11.
Score: 0.002